HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?

AuthorsDaniel Keizman, Mario A Eisenberger
JournalOncology (Williston Park, N.Y.) (Oncology (Williston Park)) Vol. 23 Issue 7 Pg. 631-2 (Jun 2009) ISSN: 0890-9091 [Print] United States
PMID19626831 (Publication Type: Comment, Journal Article)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone
Topics
  • Antineoplastic Agents, Hormonal (therapeutic use)
  • Gonadotropin-Releasing Hormone (agonists, antagonists & inhibitors)
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: